The fact that more than 90 % of IDH-mutant gliomas exhibit a hypermethylated MGMT profile is an excellent indication that in these cases the MGMT epigenetic alteration is a consequence of IDH mutations and 2-HG accumulation [10,19]. The gene discussed is IDH2; the disease is central nervous system cancer.